National Health Act 1953 Amendment determination under section 84AF Responsible persons (No. PB 16 of 2008) (Cth)
COMMONWEALTH OF AUSTRALIA
Instrument number PB 16 of 2008
Amendment determination under section 84AF of the National Health Act 1953
I, DIANA MACDONELL, Acting Assistant Secretary, Pharmaceutical Evaluation Branch, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under section 84AF of the National Health Act 1953.
Dated 2nd January 2008
DIANA MACDONELL
Acting Assistant Secretary
Pharmaceutical Evaluation Branch
Department of Health and Ageing
Amendment determination – responsible persons
1 Commencement
This instrument commences on 1 February 2008.
2 Amendment of PB 90 of 2007
Schedule 1 amends PB 90 of 2007.
Schedule 1 Amendments
[1] Schedule 1, items dealing with Amisulpride in the forms
Tablet 100 mg, Tablet 200 mg and Tablet 400 mg
omit from the columns in the order indicated:
| Amisulpride Sandoz | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |
and substitute:
| Amisulpride Sandoz | Sandoz Pty Ltd | 60 075 449 553 |
[2] Schedule 1, items dealing with Cephalexin in the form Capsule 250 mg (anhydrous)
omit from the column headed “Brand”:
Cephalexin-Lupin
and substitute:
Cephalexin Max
[3] Schedule 1, items dealing with Cephalexin in the form Capsule 500 mg (anhydrous)
omit from the column headed “Brand”:
Cephalexin-Lupin
and substitute:
Cephalexin Max
[4] Schedule 1, items dealing with Codeine with Paracetamol in the form
Tablet containing codeine phosphate 30 mg with paracetamol 500 mg
omit from the columns in the order indicated:
| Comfarol Forte | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |
and substitute:
| Comfarol Forte | Sandoz Pty Ltd | 60 075 449 553 |
[5] Schedule 1, items dealing with Diltiazem in the forms
Capsule (controlled delivery) containing diltiazem hydrochloride
180 mg, Capsule (controlled delivery) containing diltiazem hydrochloride 240 mg and Capsule (controlled delivery) containing diltiazem hydrochloride 360 mg
omit from the columns in the order indicated:
| Diltahexal CD | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |
and substitute:
| Diltahexal CD | Sandoz Pty Ltd | 60 075 449 553 |
[6] Schedule 1, after item dealing with Fosinopril in the form Tablet containing fosinopril sodium 10 mg (Fosinopril Sandoz)
insert in the columns in the order indicated:
| Fosinopril | Tablet containing fosinopril sodium 10 mg | Oral | Fosinopril Winthrop | Sandoz Pty Ltd | 60 075 449 553 |
[7] Schedule 1, after item dealing with Fosinopril in the form Tablet containing fosinopril sodium 20 mg (Fosinopril Sandoz)
insert in the columns in the order indicated:
| Fosinopril | Tablet containing fosinopril sodium 20 mg | Oral | Fosinopril Winthrop | Sandoz Pty Ltd | 60 075 449 553 |
[8] Schedule 1, after item dealing with Fosinopril with Hydrochlorothiazide in the form Tablet containing fosinopril sodium 10 mg with hydrochlorothiazide 12.5 mg (Fosinopril/HCT Sandoz 10 mg/12.5 mg)
insert in the columns in the order indicated:
| Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 10 mg with hydrochlorothazide 12.5 mg | Oral | Fosinopril/HCT Winthrop 10 mg/12.5 mg | Sandoz Pty Ltd | 60 075 449 553 |
[9] Schedule 1, after item dealing with Fosinopril with Hydrochlorothiazide in the form Tablet containing fosinopril sodium 20 mg with hydrochlorothiazide 12.5 mg (Fosinopril/HCT Sandoz 20 mg/12.5 mg)
insert in the columns in the order indicated:
| Fosinopril with Hydrochlorothiazide | Tablet containing fosinopril sodium 20 mg with hydrochlorothazide 12.5 mg | Oral | Fosinopril/HCT Winthrop 20 mg/12.5 mg | Sandoz Pty Ltd | 60 075 449 553 |
[10] Schedule 1, after item dealing with Gabapentin in the form Tablet
600 mg (Gabaran)
insert in the columns in the order indicated:
| Gabapentin | Tablet 600 mg | Oral | GenRx Gabapentin | Apotex Pty Ltd | 52 096 916 148 |
[11] Schedule 1, after item dealing with Gabapentin in the form Tablet
800 mg (Gantin)
insert in the columns in the order indicated:
| Gabapentin | Tablet 800 mg | Oral | GenRx Gabapentin | Apotex Pty Ltd | 52 096 916 148 |
[12] Schedule 1, items dealing with Influenza Vaccine
omit all five items and substitute the following four items in the columns in the order indicated:
| Influenza Vaccine | Injection containing inactivated, split virion influenza vaccine, 0.25 mL of which contains antigens representative of the following types: A/Solomon Islands/3/2006 (H1N1)-like strain 7.5 micrograms haemagglutinin; A/Brisbane/10/2007 (H3N2)-like strain 7.5 micrograms haemagglutinin; B/Florida/4/2006-like strain 7.5 micrograms haemagglutinin; 0.25 mL pre-filled syringe | Injection | Vaxigrip Junior | Sanofi Pasteur Pty Ltd | 79 085 258 797 |
| Influenza Vaccine | Injection containing inactivated, split virion influenza vaccine, 0.5 mL of which contains antigens representative of the following types: A/Solomon Islands/3/2006 (H1N1)-like strain 15 micrograms haemagglutinin; A/Brisbane/10/2007 (H3N2)-like strain 15 micrograms haemagglutinin; B/Florida/4/2006-like strain 15 micrograms haemagglutinin; 0.5 mL pre-filled syringe | Injection | Fluvax | CSL Biotherapies Pty Ltd | 66 120 398 067 |
| Influenza Vaccine | Injection containing inactivated, split virion influenza vaccine, 0.5 mL of which contains antigens representative of the following types: A/Solomon Islands/3/2006 (H1N1)-like strain 15 micrograms haemagglutinin; A/Brisbane/10/2007 (H3N2)-like strain 15 micrograms haemagglutinin; B/Florida/4/2006-like strain 15 micrograms haemagglutinin; 0.5 mL pre-filled syringe | Injection | Influvac | Solvay Biosciences Pty Ltd | 41 007 401 201 |
| Influenza Vaccine | Injection containing inactivated, split virion influenza vaccine, 0.5 mL of which contains antigens representative of the following types: A/Solomon Islands/3/2006 (H1N1)-like strain 15 micrograms haemagglutinin; A/Brisbane/10/2007 (H3N2)-like strain 15 micrograms haemagglutinin; B/Florida/4/2006-like strain 15 micrograms haemagglutinin; 0.5 mL pre-filled syringe | Injection | Vaxigrip | Sanofi Pasteur Pty Ltd | 79 085 258 797 |
[13] Schedule 1, items dealing with Isotretinoin
omit from the columns in the order indicated:
| Isotretinoin | Capsule 20 mg | Oral | Isohexal | Sandoz Pty Ltd | 60 075 449 553 |
[14] Schedule 1, items dealing with Metoprolol
omit from the columns in the order indicated:
| Metoprolol | Pack containing 15 tablets metoprolol succinate 23.75 mg (controlled release), 15 tablets metoprolol succinate 47.5 mg (controlled release) and 15 tablets metoprolol succinate 95 mg (controlled release) | Oral | Toprol-XL Titration Pack | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol | Tablet containing metoprolol succinate 190 mg (controlled release) | Oral | Toprol-XL 190 | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol | Tablet containing metoprolol succinate 23.75 mg (controlled release) | Oral | Toprol-XL 23.75 | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol | Tablet containing metoprolol succinate 47.5 mg (controlled release) | Oral | Toprol-XL 47.5 | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol | Tablet containing metoprolol succinate 95 mg (controlled release) | Oral | Toprol-XL 95 | AstraZeneca Pty Ltd | 54 009 682 311 |
[15] Schedule 1, after items dealing with Metoprolol
insert in the columns in the order indicated:
| Metoprolol succinate | Pack containing 15 tablets 23.75 mg (controlled release), 15 tablets 47.5 mg (controlled release) and 15 tablets 95 mg (controlled release) | Oral | Toprol-XL Titration Pack | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol succinate | Tablet 190 mg (controlled release) | Oral | Toprol-XL 190 | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol succinate | Tablet 23.75 mg (controlled release) | Oral | Toprol-XL 23.75 | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol succinate | Tablet 47.5 mg (controlled release) | Oral | Toprol-XL 47.5 | AstraZeneca Pty Ltd | 54 009 682 311 |
| Metoprolol succinate | Tablet 95 mg (controlled release) | Oral | Toprol-XL 95 | AstraZeneca Pty Ltd | 54 009 682 311 |
[16] Schedule 1, after item dealing with Omeprazole in the form Tablet
10 mg (as magnesium)
insert in the columns in the order indicated:
| Omeprazole | Tablet 20 mg | Oral | GenRx Omeprazole | Apotex Pty Ltd | 52 096 916 148 |
[17] Schedule 1, after item dealing with Oxybutynin in the form Tablet containing oxybutynin hydrochloride 5 mg (Oxybutynin Sandoz)
insert in the columns in the order indicated:
| Oxybutynin | Tablet containing oxybutynin hydrochloride 5 mg | Oral | Oxybutynin Winthrop | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |
[18] Schedule 1, after item dealing with Quinapril in the form Tablet 10 mg (Acquin 10)
insert in the columns in the order indicated:
| Quinapril | Tablet 10 mg (as hydrochloride) | Oral | APO-Quinapril | Apotex Pty Ltd | 52 096 916 148 |
[19] Schedule 1, after item dealing with Quinapril in the form Tablet 10 mg (Filpril)
insert in the columns in the order indicated:
| Quinapril | Tablet 10 mg (as hydrochloride) | Oral | Pharmacor Quinapril 10 | Pharmacor Pty Limited | 58 121 020 835 |
| Quinapril | Tablet 10 mg (as hydrochloride) | Oral | Quinapril-DP | Genepharm (Australia) Limited | 17 003 854 626 |
[20] Schedule 1, after item dealing with Quinapril in the form Tablet 20 mg (Acquin 20)
insert in the columns in the order indicated:
| Quinapril | Tablet 20 mg (as hydrochloride) | Oral | APO-Quinapril | Apotex Pty Ltd | 52 096 916 148 |
[21] Schedule 1, after item dealing with Quinapril in the form Tablet 20 mg (Filpril)
insert in the columns in the order indicated:
| Quinapril | Tablet 20 mg (as hydrochloride) | Oral | Pharmacor Quinapril 20 | Pharmacor Pty Limited | 58 121 020 835 |
| Quinapril | Tablet 20 mg (as hydrochloride) | Oral | Quinapril-DP | Genepharm (Australia) Limited | 17 003 854 626 |
[22] Schedule 1, after item dealing with Quinapril in the form Tablet 5 mg (Acquin 5)
insert in the columns in the order indicated:
| Quinapril | Tablet 5 mg (as hydrochloride) | Oral | APO-Quinapril | Apotex Pty Ltd | 52 096 916 148 |
[23] Schedule 1, after item dealing with Quinapril in the form Tablet 5 mg (Filpril)
insert in the columns in the order indicated:
| Quinapril | Tablet 5 mg (as hydrochloride) | Oral | Pharmacor Quinapril 5 | Pharmacor Pty Limited | 58 121 020 835 |
| Quinapril | Tablet 5 mg (as hydrochloride) | Oral | Quinapril-DP | Genepharm (Australia) Limited | 17 003 854 626 |
[24] Schedule 1, after item dealing with Sumatriptan in the form
Tablet 50 mg (as succinate) (Imigran)
insert in the columns in the order indicated:
| Sumitriptan | Tablet 50 mg (as succinate) | Oral | Sumagran 50 | Arrow Pharmaceuticals Pty Ltd | 17 003 144 170 |
[25] Schedule 1, items dealing with Trimethoprim with Sulfamethoxazole
omit from the columns in the order indicated:
| Trimethoprim with Sulfamethoxazole | Tablet 80 mg-400 mg | Oral | Septrin | Sigma Pharmaceuticals (Australia) Pty Ltd | 88 004 118 594 |
[26] Schedule 1, items dealing with Valproic Acid in the forms
Tablet (enteric coated) containing sodium valproate 200 mg and Tablet (enteric coated) containing sodium valproate 500 mg
omit from the columns in the order indicated:
| Sodium Valproate Sandoz | sanofi-aventis Australia Pty Ltd | 31 008 558 807 |
and substitute:
| Sodium Valproate Sandoz | Sandoz Pty Ltd | 60 075 449 553 |
0
0
0